The Transcranial Magnetic Stimulator Market size is expected to reach USD 569.86 Million in 2034 from USD 293.03 Million (2025) growing at a CAGR of 7.67% during 2026-2034.
The global transcranial magnetic stimulator market has grown as non-invasive neurological treatments gain popularity. Transcranial magnetic stimulation is a medical procedure that uses magnetic fields to stimulate nerve cells in the brain. It is commonly used in the treatment of depression and certain neurological conditions when traditional therapies are ineffective.
Several drivers are contributing to the growth of the transcranial magnetic stimulator market. Increasing prevalence of mental health disorders and growing awareness of advanced treatment options have encouraged adoption of this technology. Healthcare providers are exploring non-invasive therapies that reduce reliance on medications and improve patient outcomes.
Looking ahead, the market is expected to expand as research continues to explore new clinical applications for transcranial magnetic stimulation. Technological advancements may improve treatment precision and accessibility. As mental health awareness grows and healthcare systems expand treatment options, demand for this therapy is likely to increase.
MARKET SEGMENTATION
By Product Type
- Repetitive TMS
- Deep TMS
- Others (Express TMS, ppTMS, etc.)
By Application
- Therapeutics
- Diagnostics
- Research
By End User
- Hospitals
- Specialty Centers
- Others (Research Centers, Academics, etc.)
COMPANIES PROFILED
- Neurosoft, Magstim, Nexstim plc, MagVenture Inc, BrainsWay, Seber Medical, Soterix Medical Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Repetitive TMS Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Deep TMS Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Others (Express TMS, ppTMS, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET: BY END USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End User
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Specialty Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Others (Research Centers, Academics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End User
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End User
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End User
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End User
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End User
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Neurosoft
- 9.2.2 Magstim
- 9.2.3 Nexstim Plc
- 9.2.4 MagVenture Inc
- 9.2.5 BrainsWay
- 9.2.6 Seber Medical
- 9.2.7 Soterix Medical Inc